​

Centessa Pharmaceuticals (CNTA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Centessa Pharmaceuticals Revenue Highlights

00

Main Segment (Y)

Reportable Segment

Main Geography (Y)

Lixivaptan

Centessa Pharmaceuticals Revenue by Period

Centessa Pharmaceuticals Revenue by Year

DateRevenueChange
2025-12-31-100.00%
2024-12-31--100.00%
2023-12-31$6.85M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Centessa Pharmaceuticals generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Centessa Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30--100.00%
2025-03-31$15.00M1475.21%
2024-12-31$952.25K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$6.91M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Centessa Pharmaceuticals generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Centessa Pharmaceuticals Revenue Breakdown

Centessa Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 21
Reportable Segment$15.00M-
Lixivaptan-$200.00M

Centessa Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Mar 25
Reportable Segment-$15.00M

Centessa Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21
Lixivaptan$200.00M

Centessa Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 21: Lixivaptan (100.00%).

Centessa Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AAPGAscentage Pharma Group$980.65M$141.22K
RAREUltragenyx Pharmaceutical$673.00M$159.93M
ZLABZai Lab$460.16M$116.09M
LEGNLegend Biotech$285.14M$93.99M
SLNOSoleno Therapeutics$190.41M$66.02M
XENEXenon Pharmaceuticals$7.50M-
CGONCG Oncology$4.04M$1.67M
APGEApogee Therapeutics--
CNTACentessa Pharmaceuticals--
DYNDyne Therapeutics--
CELCCelcuity-$154.00K

CNTA Revenue FAQ

What is Centessa Pharmaceuticals’s yearly revenue?

Centessa Pharmaceuticals's yearly revenue for 2025 was $0, representing an increase of 100.00% compared to 2024. The company's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. CNTA's yearly revenue for 2023 was $6.85M, representing an increase of 100.00% compared to 2022.

What is Centessa Pharmaceuticals’s quarterly revenue?

Centessa Pharmaceuticals's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a -100.00% decrease from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). CNTA's quarterly revenue for Q1 2025 was $15M, a 1475.21% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Centessa Pharmaceuticals’s revenue growth rate?

Centessa Pharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was -100.00%, and for the last 5 years (2021-2025) was 0%.

What are Centessa Pharmaceuticals’s revenue streams?

Centessa Pharmaceuticals's revenue streams in c 25 are Reportable Segment

What is Centessa Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Centessa Pharmaceuticals was Reportable Segment. This segment made a revenue of $15M, representing 100.00% of the company's total revenue.